PDS BIOTECHNOLOGY CORP stock forecast: down to 3.90 USD PDSB stock price prognosis

STOCK

Forecast for Wed 19 Jun 2024 price 4.43

PDS BIOTECHNOLOGY CORP stock price forecast for further price development down to -20.04% (time horizon: 1 day) and price target of 3.90 USD. Short-term (time horizon: 2 weeks) PDS BIOTECHNOLOGY CORP share price prediction for 2024-06-19 with daily closed price projections

Key Facts

Symbol PDSB 

ISIN US70465T1079 

CUSIP 70465T107


Currency USD


Category Pharmaceutical Preparations

Forecast price change %

Relative Strength Index (RSI)

Finance numbers

Earnings per share -0.89


On our site we made daily predictions for finance products based on statistical analysis. You can export / download forecasted data as CSV file, no login required. The information can be used for day trading.

Summerized Form 10-K with GPT-2

The clinical trials are planned to be conducted in Brazil. How does cancer immunotherapy work? Preclinical development is ongoing. More than 7,000 of these will prove fatal. These include cancers such as ovarian, breast, colorectal and lung cancers. PDS0103 is currently in late preclinical development. These issued patents will expire in 2031-2034, or later if patent term extension applies. DOTAP Chloride Enantiomer License Agreement with Merck Eprova AG. 20 Index The term of the CRADA is five (5) years, starting February 2, 2016. The CRADA may be terminated by either party at any time by mutual written consent. In this event, the BLA must be resubmitted with the additional information. Our approach to compliance may evolve over time in light of these types of developments. Medical data is considered sensitive data that merits stronger safeguards. As of December 31, 2020, we had 15 employees and 5 consultants. 44 Index The successful development of immunotherapies is highly uncertain. In addition, there is a natural transition period when a new CRO commences work. We expect the impact of COVID-19 on the FDA's operations will continue to evolve. The Leahy-Smith Act includes a number of significant changes to United States patent law. The changes included in the Tax Act are broad and complex.

Summerized Form 10-K with GPT-2 https://www.sec.gov/Archives/edgar/data/1472091/000114036121009142/0001140361-21-009142.txt
Candlestick patterns

Candlestick patterns can be used as additional information for price prediction. Following list show which pattern applies on latest price information.

  • Meta analyst score 34.72/100
    • Not in ideal financial position.
    • Historical view, profit is not growing.
    • Company revenue is not growing faster compared with the industry.
    • Stock price is under book price value.

Institutional ownership list is based on filling form information

Holding name Date Amount
A - BARCLAYS PLC 2023-06-30 5571
A - OSAIC HOLDINGS, INC. 2023-06-30 2000
VANGUARD GROUP INC 2023-03-31 1298475
EP Wealth Advisors, LLC 2022-12-31 10207
EP Wealth Advisors, LLC 2023-03-31 38337

Fund ownership list is based on filling form information

Fund name Date Amount Profile
MORGAN STANLEY PATHWAY FUNDS 2023-11-30 1007 Long
ProShares Trust 2023-11-30 2248 Long
ProShares Trust 2023-11-30 1296 Long
ProShares Trust 2023-11-30 63 Long
Fidelity Concord Street Trust 2023-11-30 41270 Long


Bollinger Bollinger Bands for PDS BIOTECHNOLOGY CORP can provide the information where the market is moving based on price information.


PDS BIOTECHNOLOGY CORP Short Volume Ratio is shown in the diagram. Short volume sales can be seen as an investor sentiment.



Converting prices to returns PDS BIOTECHNOLOGY CORP.


On-Balance Volume information for PDS BIOTECHNOLOGY CORP. On-Balance Volume information can be an indicator for bullish or bearish outcome.



Accumulation / Distribution (A/D) indicator information for PDS BIOTECHNOLOGY CORP. The indicator identify divergences between price and volume flow.


Aroon Oscillator information for PDS BIOTECHNOLOGY CORP. The trend-following indicator can show the strengh of a current trend and likelihood that trend can continue.


Average Directional Index (ADX) information for PDS BIOTECHNOLOGY CORP. The index can be used to identify the strengh of a trend.


Moving Average Convergence Divergence (MACD) for PDS BIOTECHNOLOGY CORP. The indicator helps to predict trend direction and the momentum of the trend.


Stochastic Oscillator as momentum indicator for PDS BIOTECHNOLOGY CORP. The indicator is useful for identifying overbought and oversold levels.


Relative Strength Index (RSI) for PDS BIOTECHNOLOGY CORP. RSI is a momentum oscillator that measures the speed and change of price development. The momentum indicator was created by analyst Welles Wilder. The result compares recent gains and losses over restricted time period. Primary usage of the indicator is to identify overbought or oversold signals. When RSI indicator reaches a value of 70 it could mean that speculators should consider selling, suggests Wilder and Chong. Or vice versa when selling excess at which the RSI Indicators show a value of 30 [ Relative Strength Index for Developing Effective Trading Strategies in Constructing Optimal Portfolio ].


Heikin Ashi trading signals are generated based on the Heikin Ashi candles, which are a type of candlestick that smooths out the price action and can help to identify trends. Heikin Ashi signals can be used to identify both long and short trading opportunities.


The awesome oscillator is a momentum indicator that measures the speed and strength of price movements. It is calculated by subtracting a 34-period simple moving average (SMA) from a 5-period SMA.


The Parabolic SAR indicator is a trend-following indicator that uses a series of dots to indicate when a trend is likely to reverse. The Parabolic SAR is a lagging indicator, meaning that it does not predict reversals, but rather confirms them after they have already occurred.


Moving Average Crossover


52W High 52W Low Market Cap

Similar shares


PDS BIOTECHNOLOGY CORP on Nasdaq

PDS BIOTECHNOLOGY CORP on finviz

Figure below show the stock predictions.
Date Closing price Prediction was updated
2024-05-24 3.90 2024-04-24 08:06
2024-05-22 3.84 2024-04-24 08:06
2024-05-23 3.87 2024-04-24 08:06
2024-05-20 3.76 2024-04-24 08:06
2024-05-21 3.79 2024-04-24 08:06
2024-06-10 4.23 2024-04-24 08:06
2024-06-11 4.26 2024-04-24 08:06
2024-06-07 4.21 2024-04-24 08:06
2024-05-30 4.03 2024-04-24 08:06
2024-05-29 4.01 2024-04-24 08:06
2024-06-05 4.15 2024-04-24 08:06
2024-06-03 4.09 2024-04-24 08:06
2024-06-04 4.12 2024-04-24 08:06
2024-05-31 4.05 2024-04-24 08:06
2024-05-27 3.93 2024-04-24 08:06
2024-05-28 3.97 2024-04-24 08:06
2024-06-06 4.17 2024-04-24 08:06
2024-06-13 4.32 2024-04-24 08:06
2024-06-14 4.35 2024-04-24 08:06
2024-06-12 4.29 2024-04-24 08:06
2024-06-19 4.43 2024-04-24 08:07
2024-06-17 4.38 2024-04-24 08:06
2024-06-18 4.40 2024-04-24 08:06
2024-05-14 3.62 2024-04-24 08:06
2024-05-03 3.48 2024-04-24 08:06
2024-05-13 3.55 2024-04-24 08:06
2024-05-15 3.65 2024-04-24 08:06
2024-05-16 3.67 2024-04-24 08:06
2024-04-26 3.20 2024-04-24 08:06
2024-05-09 3.54 2024-04-24 08:06
2024-04-29 3.30 2024-04-24 08:06
2024-04-30 3.27 2024-04-24 08:06
2024-05-17 3.71 2024-04-24 08:06
2024-05-02 3.39 2024-04-24 08:06
2024-05-06 3.45 2024-04-24 08:06
2024-05-07 3.47 2024-04-24 08:06
2024-05-08 3.52 2024-04-24 08:06
2024-05-01 3.35 2024-04-24 08:06
2024-05-10 3.52 2024-04-24 08:06

The forecast (dashed curve) of the share price performance is based on historical data. Our forecast model is based on mathematical, statistical methods. The website offers price forecasts and analysis tools for equities and other securities, which are exclusively based on the prices of these securities in the past. Information about these prices is provided to us by third parties. Although we believe, If we believe that our sources are reliable, we cannot guarantee the accuracy, completeness, timeliness and correct sequencing of this information. We do not investigate the issuers of the securities to which our forecasts relate, nor do we consider any financial data or other data of such issuers with the exception of the past prices of the securities. Therefore, our forecasts do not constitute an analysis of other commercial or financial factors or circumstances, that may be relevant for future security price flows. Investments require additional considerations. Our forecasts cannot reflect the specific situation. Experience and risk profile of an individual investor or the tax implications an investment may have for the investor. Although we believe that our mathematical models are a tool to try to explore the possibility for future price development with the help of past performance, such developments are subject to a multitude of different influences. and therefore not really predictable. We cannot guarantee the success of any investment you make based on the information published here. This website is for information purposes only. All information and data on this website cannot be guaranteed to be accurate, accuracy, completeness and appropriateness - neither explicit nor implicit.